Document is current
Any future updates will be listed below
-
Authors
Cheruiyot, Ngetich B.
Nagi, Sachiyo
Chadeka, Asena E.
Takeuchi, Rie
Sassa, Miho
Felix, Bahati
Kobayashi, Noriko
Moriyasu, Taeko
Masaku, Janet
Okomo, Gordon
Ouma, Collins
Njomo, Doris
Njenga, Sammy M.
Hamano, Shinjiro https://orcid.org/0000-0003-3881-8337
-
Funding
Funding for this research was provided by:
JSPS (17H01685, 21H04852, 14J10486, S2509, 19K14188)
JICA and AMED (JP23jm0110027)
MEXT
- License Information
-
More Information
Article History
Received: 28 January 2024
Accepted: 25 April 2024
First Online: 14 May 2024
Declarations
:
: Ethical clearance for the study was obtained from the scientific and ethics review unit of the Kenya Medical Research Institute (KEMRI, SSC No. 3092) and from the institutional ethical review board of Nagasaki University, Japan. Permission was also sought from the Ministry of Health and Ministry of Education sub-county authorities, who were instrumental in the survey operation. Local administrators, including the area chief, were given notification of the study. The school head teachers and committees were informed of the research and briefed on the study’s purpose before its commencement. All the parents/guardians of the pre-school children signed a written informed consent while pre-school children gave assent to participate before the beginning of the study. Praziquantel prescription (40 mg/kg) was administered to all <i>S. mansoni</i>-positive children, and those found infected with soil-transmitted helminths were treated with albendazole (400 mg) following WHO guidelines. A certified clinical officer administered the medication.
: The authors received consent for publication from Kenya Medical Research Institutes.
: The authors declare that they have no competing interests.
